Our Engagement
30 Years From Now
- Health at Bayer
-
Pharmaceuticals
- Treatment Areas
- Innovation & Technologies
- Cell and Gene Therapy
-
Sustainability
- Patient Access Charter
- Leadership Perspective
- Strengthening Healthcare Access
-
Empowering Women, Globally
- Boosting Family Planning Usage through Digital Channels
- Capacity building: Addressing Root Causes through Partnerships
- Impact at Scale: The Challenge Initiative
- Promoting Awareness: World Contraception Day (WCD) & the Your Life Campaign
- Providing Accessible and Affordable Contraceptives
- Enabling Family Planning in Humanitarian Settings
- Fighting Neglected Tropical Diseases
- Moving Non-Communicable Diseases Care Forward
- Ensuring a Sustainable Product Supply
- Delivering Better Cancer Care
- Transparency
- News & Stories
- Personal Health
- Report a Side Effect
- Medical Counterfeits
The global population of people over 60 will grow to two billion by 2050*. The demographic phenomenon of aging will radically change healthcare systems and government policies worldwide over the next three decades and beyond. On the cusp of this new era, Bayer's 30 Years From Now turns to global industry leaders at the forefront of medicine, science and technology for unique insights into the future of healthy aging.
Related Articles
Quelle:
* WHO, 2018: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health